Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients
Authors:
- M. PerticoneMPM. Perticone
- S. MiceliSMS. Miceli
- I. LainoILI. Laino
- E.J. TassoneETE.J. Tassone
- R.D. GrembialeR.D. Grembiale
- F. AndreozziF. Andreozzi
- G. SestiGSG. Sesti
- F. PerticoneFPF. Perticone
- 15 March 2010
- journal article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 21 (7) , 485-491
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- Relation of Plasma Insulin Levels to Forearm Flow-Mediated Dilatation in Healthy VolunteersThe American Journal of Cardiology, 2006
- Letter to the EditorArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseHepatology, 2005
- Angiotensin II Impairs the Insulin Signaling Pathway Promoting Production of Nitric Oxide by Inducing Phosphorylation of Insulin Receptor Substrate-1 on Ser 312 and Ser 616 in Human Umbilical Vein Endothelial CellsCirculation Research, 2004
- Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic associationHepatology, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.Diabetes Care, 2000
- Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitusJACC, 1996
- Nitric oxide release accounts for insulin's vascular effects in humans.Journal of Clinical Investigation, 1994